University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Risk of serious COVID-19 outcomes among adults with asthma in Scotland : a national incident cohort study

dc.contributor.authorShi, Ting
dc.contributor.authorPan, Jiafeng
dc.contributor.authorVasileiou, Eleftheria
dc.contributor.authorRobertson, Chris
dc.contributor.authorSheikh, Aziz
dc.contributor.authorPublic Health Scotland and the EAVE II Collaborators
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.date.accessioned2022-04-07T09:04:01Z
dc.date.available2022-04-07T09:04:01Z
dc.date.issued2022-04
dc.descriptionWe thank the EAVE II Patient Advisory Group for their support. EAVE II is funded by the Medical Research Council (MR/R008345/1) with the support of BREATHE—The Health Data Research Hub for Respiratory Health [MC_PC_19004], which is funded through the UK Research and Innovation Industrial Strategy Challenge Fund and delivered through Health Data Research UK. This research is part of the Data and Connectivity National Core Study, led by Health Data Research UK in partnership with the Office for National Statistics and funded by UK Research and Innovation (grant reference MC_PC_20058). Additional support has been provided through Public Health Scotland and Scottish Government DG Health and Social Care and the Data and Connectivity National Core Study, led by Health Data Research UK in partnership with the Office for National Statistics and funded by UK Research and Innovation.en
dc.description.statusPeer revieweden
dc.format.extent8
dc.format.extent612357
dc.identifier215113507
dc.identifier98e393c2-c747-4d44-8bec-0383c0e49381
dc.identifier35033224
dc.identifier85127209815
dc.identifier.citationShi, T, Pan, J, Vasileiou, E, Robertson, C, Sheikh, A & Public Health Scotland and the EAVE II Collaborators 2022, 'Risk of serious COVID-19 outcomes among adults with asthma in Scotland : a national incident cohort study', The Lancet. Respiratory medicine, vol. 10, no. 4, pp. 347-354. https://doi.org/10.1016/S2213-2600(21)00543-9en
dc.identifier.doi10.1016/S2213-2600(21)00543-9
dc.identifier.iss4en
dc.identifier.issn2213-2600
dc.identifier.otherPubMedCentral: PMC8758152
dc.identifier.urihttps://hdl.handle.net/2164/18363
dc.identifier.vol10en
dc.language.isoeng
dc.relation.ispartofThe Lancet. Respiratory medicineen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectSDG 9 - Industry, Innovation, and Infrastructureen
dc.subjectAdolescenten
dc.subjectAdulten
dc.subjectAsthma/drug therapyen
dc.subjectCOVID-19/epidemiologyen
dc.subjectCOVID-19 Vaccinesen
dc.subjectCohort Studiesen
dc.subjectHospitalizationen
dc.subjectHumansen
dc.subjectSARS-CoV-2en
dc.subjectScotland/epidemiologyen
dc.subjectR Medicineen
dc.subjectMedical Research Council (MRC)en
dc.subjectMR/R008345/1en
dc.subject.lccRen
dc.titleRisk of serious COVID-19 outcomes among adults with asthma in Scotland : a national incident cohort studyen
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Shi_etal_LRM_Risk_Serious_COVID_VOR.pdf
Size:
598 KB
Format:
Adobe Portable Document Format

Collections